WG
ACHV icon

Winton Group’s Achieve Life Sciences ACHV Stock Holding History

Winton Group’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$278K Buy
+42,500
New +$203K 0.01% 910

Other funds holding ACHV

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Winton Group's ACHV Position: Q2 2026 in Review

Winton Group opened a new position in Achieve Life Sciences (ACHV) in Q2 2026: 42,500 shares worth $278K. The stake represents 0.01% of the portfolio and ranks #910 among its holdings.

111 funds tracked by Wall St. Rank hold ACHV as of Q2 2026.

  • Winton Group held 42,500 shares of Achieve Life Sciences worth $278K as of Q2 2026.
  • Achieve Life Sciences was a new Winton Group position in Q2 2026.
  • Achieve Life Sciences made up 0.01% of Winton Group's portfolio in Q2 2026, its #910 holding.
  • 111 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2026.

Based on Winton Group's 13F filing for Q2 2026, filed 7 Aug 2026.